Sheffield, United Kingdom
Sheffield, United Kingdom

Ansys, Inc. is an engineering simulation software developer headquartered south of Pittsburgh in the Southpointe business park in Cecil Township, Pennsylvania, United States. One of its most significant products is Ansys CFD, a proprietary computational fluid dynamics program. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

PITTSBURGH, May 24, 2017 /PRNewswire/ -- Customers of Samsung Electronics and ANSYS (NASDAQ: ANSS) are empowered to create the next generation of robust and reliable electronic devices thanks to Samsung's certification and enablement of ANSYS solutions. This certification of self...


-- PNY, a leading supplier of NVIDIA® Quadro® professional graphics solutions to system integrators, value-added resellers, and distributors, is showcasing the new family of NVIDIA Quadro Pascal™ architecture professional GPU-fueled solutions, including:  NVIDIA Quadro VCA (Visual Computing Appliance) Certified Systems featuring eight ultra-high-end Quadro P6000 GPUs for interactive photorealistic rendering with unmatched performance, the unique mixed-mode compute and NVLink™ capable Quadro GP100 running advanced CAE software, as well as exciting new Quadro embedded (MXM) solutions.Announced at GTC, the Quadro VCA Certified System Program enables select PNY partners to offer powerful turnkey rendering appliances, capable of supporting multiple users simultaneously, over network environments ranging from departmental LANs to the Internet.  Running NVIDIA's innovative VCA software, these systems offer batch or interactive streaming rendering options, intuitive browser-based queue management, support for NVIDIA Iray® and MDL technology for ease-of-use, and are exactingly specified, tested, and certified for maximum uptime.  Other GPU-accelerated rendering options like SOLIDWORKS® Visualize Professional and Chaos Group's V-Ray are also supported.Demonstrations and displays at the PNY booth will include:Features eight ultra-high-end Quadro P6000 GPUs running SOLIDWORKS Visualize Professional and NVIDIA VCA software on a VCA Certified System, which offers unmatched stability and performance for mission-critical raytracing rendering workflows driven directly from CAD files.Client workstation networked to the VCA Certified System for accelerated photorealistic raytracing rendering.New embedded solutions offering the same powerful Quadro PascalGPU performance in a small, low-power MXM form factor for ruggedized or custom hardware applications.NVIDIA Quadro GP100 graphic boards paired with NVLinkto double the GPU memory footprint and scale application performance by enabling bandwidth GPU-to-GPU data transfers at up to 80 GB/s.ANSYS® 18 engineering simulation software GPU accelerated with the Quadro GP100 using double precision (FP64) and fast HBM2 memory to both compute, validate and visualize engineering simulations."We invite developers and designers to come by our booth to see how the latest Pascal family of Quadro GPUs, including the uniquely compute enabled ultra-high-end, are changing the future of manufacturing, computation, visualization, simulation and VR workflows," said Steven Kaner,Vice President Sales & Marketing, PNY. "This transformative product, and offerings from our new VCA Certified System Program are opening up new frontiers across disciplines ranging from CAE to deep learning and AI, visualization and simulation, and beyond."NVIDIA Quadro graphics solutions from PNY are certified on 100+ professional software applications, come with a three-year warranty and are available from system integrators, value-added resellers, and distributors.  PNY Technologies, Inc. is the authorized NVIDIA Quadro channel partner for the Americas and Europe. For additional information, visit PNY at http:// www.pny.com/ pnypro or contact gopny@pny.com ( mailto:bfp@pny.com ).Celebrating over 30 years of B2B, OEM and Channel expertise, PNY Technologies, Inc. is a leading supplier of NVIDIA® Quadro®, NVS® and GeForce® Graphics Boards, and manufacturer of PNY GeForce Graphics Boards, Solid State Drives, and USB Flash Drives.  Headquartered in Parsippany, N.J., PNY maintains facilities across North America, Europe and Asia.  PNY's commitment to process improvement, quality, and customer service and support, has made the company a supplier of record to vendors across markets ranging from photorealistic rendering to Deep Learning (AI).The PNY logo is a registered trademark of PNY Technologies, Inc. NVIDIA and Quadro are trademarks and/or registered trademarks of NVIDIA Corporation.  All other trademarks are the property of their respective owners. Copyright © 2017 PNY Technologies, Inc. All rights reserved.


Grant
Agency: European Commission | Branch: FP7 | Program: CP | Phase: ICT-2009.5.3 | Award Amount: 15.53M | Year: 2011

The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of 56 billion per annum. Current therapies are inadequate and we do not have sufficient tools to predict disease progression or response to current or future therapies. Our consortium, Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM), brings together the exisiting clinical consortia (EvA FP7, U-BIOPRED IMI and BTS Severe Asthma), and expertise in physiology, radiology, image analysis, bioengineering, data harmonization, data security and ethics, computational modeling and systems biology. We shall develop an integrated multi-scale model building upon existing models. This airway model will be comprised of an integrated micro-scale and macro-scale airway model informed and validated by omic data and ex vivo models at the genome-transcriptome-cell-tissue scale and by CT and functional MRI imaging coupled to detailed physiology at the tissue-organ scale utilising Europes largest airway disease cohort. Validation will be undertaken cross-sectionally, following interventions and after longitudinal follow-up to incorporate both spatial and temporal dimensions. AirPROM has a comprehensive data management platform and a well-developed ethico-legal framework. Critically, AirPROM has an extensive exploitation plan, involving at its inception and throughout its evolution those that will develop and use the technologies emerging from this project. AirPROM therefore will bridge the critical gaps in our clinical management of airways disease, by providing validated models to predict disease progression and response to treatment and the platform to translate these patient-specific tools, so as to pave the way to improved, personalised management of airways disease.


Grant
Agency: GTR | Branch: EPSRC | Program: | Phase: Research Grant | Award Amount: 1.94M | Year: 2013

The increasing amounts of renewable energy present on the national grid reduce C02 emissions caused by electrical power but they fit into an electrical grid designed for fossil fuels. Fossil fuels can be turned on and off at will and so are very good at matching variations in load. Renewable energy in the form of wind turbines is more variable (although that variability is much more predictable than most people think) and there is a need for existing power plants to operate much more flexibly to accommodate the changing power output from wind, tidal and solar power. This work brings together five leading Universities in the UK and a number of industrial partners to make conventional power plants more flexible. The research covers a wide range of activities from detailed analysis of power station parts to determine how they will respond to large changes in load all the way up to modelling of the UK electrical network on a national level which informs us as to the load changes which conventional power plants will need to supply. The research work is divided up into a number of workpackages for which each University is responsible together they contribute to four major themes in the proposal: Maintaining Plant Efficiency, Improving Plant Flexibility, Increasing Fuel Flexibility and Delivering Sustainability. Cambridge University will be conducting research into wet steam methods. Water is used as the working fluid in power plant as it has excellent heat transfer properties. However in the cold end of power extraction turbine the steam starts to condense into water and droplets form this is especially a problem at part load. The work at Cambridge will allow this process to be predicted better and lead to better designs. Durham University will contribute two different work packages: modelling work of the entire UK power system and the introduction of the worlds first dynamically controlled clearance seal. The modelling work will enable the requirements for plant flexibility to be determined accurately. The dynamic seal developed in conjunction with a major UK manufacturer will allow the turbine to maintain performance as the load varies. Oxford University - Improved Heat Transfer Methods for Turbine Design. The output from this work will be a highly accurate coupled fluid flow and heat transfer calculations that will enable designers to better predict the thermal transients inside power stations. Leeds and Edinburgh University will lead work on increasing the use of biomass fuels. The modelling work at Leeds will allow plant operators to devise suitable measures to minimise the environmental impact of burning biomass. Leeds and Edinburgh University will contribute the development of a Virtual Power Plant Simulation Tool This work acts as a bridge between the different project partners as inputs from the models produced at Durham, Cambridge, Oxford and Leeds are combined. This tool based on the latest research findings can be used to optimize transient operations such as fast start-up and load following as wind turbine output varies.


Grant
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: PHC-30-2015 | Award Amount: 5.00M | Year: 2016

Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise. It is dominated by two conditions, Aortic Stenosis and Mitral Regurgitation, both of which are associated with significant morbidity and mortality, yet which pose a truly demanding challenge for treatment optimisation. By combining multiple complex modelling components developed in recent EC-funded research projects, a comprehensive, clinically-compliant decision-support system will be developed to meet this challenge, by quantifying individualised disease severity and patient impairment, predicting disease progression, ranking the effectiveness of alternative candidate procedures, and optimising the patient-specific intervention plan. This algorithmically-driven process will dramatically improve outcomes and consistency across Europe in this fast-growing patient group, maximising individual, societal and economic outcomes.


Grant
Agency: European Commission | Branch: H2020 | Program: MSCA-ITN-ETN | Phase: MSCA-ITN-2014-ETN | Award Amount: 3.70M | Year: 2015

VPH-CaSE is focused on state-of-the-art developments in personalised cardiovascular support, underpinned by simulation and experimentation, building on the foundations of the Virtual Physiological Human (VPH) Initiative. The Individual Research Projects of 14 ESRs provide knowledge exchange across three research clusters (i) Cardiac tissue function and cardiac support (ii) Cardiovascular haemodynamics - pathology and intervention (iii) Image-based diagnosis and imaging quality assurance. The work will be directed by the needs of industrial and clinical Beneficiaries and Partners, providing a truly multi-disciplinary, multi-sectoral environment for the ESRs. This will combine the expertise of nine core Beneficiaries (5 academic, 4 industrial) and 10 Partners (5 clinical, 4 industrial, 1 academic) to provide scientific support, secondments and training. VPH-CaSE will foster the development of ESRs within a collaborative environment. The recruited researchers will find themselves in an enviable position to leverage the expertise of a strategic sector of the European medical devices/simulation industry and engage with the issues faced by clinical experts in the domain of cardiac medicine and cardiovascular support. Their postgraduate studies will be informed by a translational bias that delivers a competitive skill-set, equipping them to address the challenges presented by a career at the cutting edge of technological innovation in healthcare delivery. The inclusion of a technology translation SME within the consortium is designed to promote the delivery of novel, tangible research outputs, providing benefits to a breadth of European sectors (eg. biomedical, clinical, VPH). The ultimate vision is the production of VPH-capable scientists with experience of tight integration of academic/industrial/clinical areas, able to apply their skills to real life scenarios, accelerating the acceptance of innovative and effective healthcare in the clinic.


Grant
Agency: European Commission | Branch: FP7 | Program: CP | Phase: ICT-2009.5.2 | Award Amount: 4.88M | Year: 2011

Vascular stenting is an invasive procedure for the treatment of occlusive vascular diseases; a small wire mesh tube called a stent is permanently placed in the artery or vein to help it remain open. The procedure is called angioplasty. Originally developed to treat sever occlusions of coronary arteries, thanks to its good results, stenting found an expanding indication also for the treatment of occlusions in peripheral arteries. Around 20% of the population over 60 years old have peripheral arterial disease, and in a fifth of them symptoms can become severe and progressive, causing major lifestyle limitation; in many of these cases a stent can solve the problem effectively and with moderate risk for the patient. As common for many other implantable devices, the expansion of the indication is also producing new complications. In particular, the risk of stent rupture, which in coronaries is near to zero, is becoming an increasing source of concerns for devices placed in peripheral arteries. The variability of the incidence of this complication, that in some recent clinical studies affect 30% of the patients, suggest that problem is not only due to the design of the device, but also to factors related to the patient functional anatomy and lifestyle, and to the surgical procedure. The RT3S project aim to develop and validate a sophisticated patient-specific, probabilistic model of the fatigue-fracture of a stent, integrated in a computer-aided surgery planning application, implemented to run in real-time during the surgical planning, so as to provide advice of the risk of stent rupture while the surgeon is planning the operation. The real time software library, easy embeddable in any existing application, will make possible to include the assessment of risk for stent fracture in all software solutions for computer-aided planning, training and intervention of peripheral vascular angioplasty procedures.


Patent
ANSYS Inc. | Date: 2014-04-11

A processor-implemented system is provided for creating an engineering model for analyzing a physical object. One or more model operations are performed based at least in part on a computer-assisted-design (CAD) model. An engineering model is generated based at least in part on a mapping data structure that associates the CAD model with the engineering model.


Patent
ANSYS Inc. | Date: 2013-11-29

In a system for facilitating mesh generation corresponding to a volumetric, prismatic object, generalized polyhedrons representing at least a portion of a layer of the volumetric object are transformed into a set of convex polyhedrons based on, at least in part, the prismatic properties of the volumetric object. The convex polyhedrons corresponding to a layer are decomposed into a set of tetrahedrons by accounting for an intersecting and/or overlapping edge of a polyhedron in an adjacent layer, so that the set of tetrahedrons automatically, i.e., without having to enforce any continuity requirements after tetrahedron generation, forms a mesh of that is continuous with tetrahedrons corresponding to the adjacent layer.


Patent
ANSYS Inc. | Date: 2014-06-11

In a system for facilitating mesh generation corresponding to a volumetric, prismatic object, generalized polyhedrons representing at least a portion of a layer of the volumetric object are transformed into a set of convex polyhedrons based on, at least in part, the prismatic properties of the volumetric object. The convex polyhedrons corresponding to a layer are decomposed into a set of tetrahedrons by accounting for an intersecting and/or overlapping edge of a polyhedron in an adjacent layer, so that the set of tetrahedrons automatically, i.e., without having to enforce any continuity requirements after tetrahedron generation, forms a mesh of that is continuous with tetrahedrons corresponding to the adjacent layer.

Loading ANSYS Inc. collaborators
Loading ANSYS Inc. collaborators